Europe — EMA

Pamifos (Pamidronate Disodium)

Request sourcing

Pack/s

What is Pamidronate Disodium?

Pamidronate Disodium, the active ingredient in Pamifos, is a bisphosphonate presented as a 60 mg/5 ml solution for intravenous use. It is employed to manage bone resorption disorders in adult patients. GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Pamidronate Disodium used for?

Pamifos is a bisphosphonate that acts on skeletal ... ... .... ... .... ... .... ... ... .... ... ... ... ... ... ... ... ... ... ... ...

- Hyper‑hyper‑ .... ... .... ... ... ... ... .... ... ... ... ... ... ...: ... - ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...: - ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... : - ... ... ... .... ... ... … - ... ... ...

What are the side effects of Pamidronate Disodium?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →